NCT04858776 - Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 8, 2022

Primary Completion Date

May 31, 2025

Study Completion Date

December 31, 2026

Conditions

Iliofemoral; Thrombosis

Interventions

COMBINATION_PRODUCT

Perivascular dexamethasone

Dexamethasone delivery around target vein segment(s)

COMBINATION_PRODUCT

Perivascular sham

Saline delivery around target vein segment(s)

Trial Locations (15)

11794

NOT_YET_RECRUITING

Stony Brook University Hospital, Stony Brook

20782

RECRUITING

Medstar Health Research Institute, Hyattsville

23452

RECRUITING

Sentara Norfolk General Hospital, Norfolk

27607

RECRUITING

NC Heart and Vascular Research, Raleigh

33060

RECRUITING

University of South Florida, Tampa

43214

RECRUITING

OhioHealth Research Institute, Columbus

60611

RECRUITING

Northwestern University Hospital, Chicago

70360

RECRUITING

CIS Clinical Research, Houma

74006

RECRUITING

St John Health System, Bartlesville

75020

RECRUITING

CardioVoyage, Denison

77494

RECRUITING

University of Texas, Houston, Houston

98004

RECRUITING

Lake Washington Vascular, Bellevue

06820

RECRUITING

Vascular Care Connecticut, Darien

H91 YR71

RECRUITING

Galway University Hospital, Galway

SE1 7EH

RECRUITING

Guy's and St. Thomas Hospital, London